These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31164942)

  • 1. Stereo- and regioselective hydroboration of 1-
    Dahlqvist A; Furevi A; Warlin N; Leffler H; Nilsson UJ
    Beilstein J Org Chem; 2019; 15():1046-1060. PubMed ID: 31164942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain.
    Pal KB; Mahanti M; Huang X; Persson S; Sundin AP; Zetterberg FR; Oredsson S; Leffler H; Nilsson UJ
    Org Biomol Chem; 2018 Aug; 16(34):6295-6305. PubMed ID: 30117507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epimers Switch Galectin-9 Domain Selectivity: 3
    Mahanti M; Pal KB; Sundin AP; Leffler H; Nilsson UJ
    ACS Med Chem Lett; 2020 Jan; 11(1):34-39. PubMed ID: 31938460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.
    Cumpstey I; Carlsson S; Leffler H; Nilsson UJ
    Org Biomol Chem; 2005 May; 3(10):1922-32. PubMed ID: 15889175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.
    Rajput VK; Leffler H; Nilsson UJ; Mukhopadhyay B
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3516-20. PubMed ID: 24973029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Design of a Monosaccharide Ligand Targeting Galectin-8.
    Bohari MH; Yu X; Kishor C; Patel B; Go RM; Eslampanah Seyedi HA; Vinik Y; Grice ID; Zick Y; Blanchard H
    ChemMedChem; 2018 Aug; 13(16):1664-1672. PubMed ID: 29926535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.
    Tejler J; Skogman F; Leffler H; Nilsson UJ
    Carbohydr Res; 2007 Sep; 342(12-13):1869-75. PubMed ID: 17407769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of tricyclic carbohydrate-benzene hybrids as selective inhibitors of galectin-1 and galectin-8 N-terminal domains.
    Wu C; Yong C; Zhong Q; Wang Z; Nilsson UJ; Zhang Y
    RSC Adv; 2020 May; 10(33):19636-19642. PubMed ID: 35515421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development.
    Dussouy C; Kishor C; Lambert A; Lamoureux C; Blanchard H; Grandjean C
    Chem Biol Drug Des; 2020 Oct; 96(4):1123-1133. PubMed ID: 32220037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals.
    van Klaveren S; Sundin AP; Jakopin Ž; Anderluh M; Leffler H; Nilsson UJ; Tomašič T
    ChemMedChem; 2022 Mar; 17(6):e202100575. PubMed ID: 34913595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.
    Hassan M; van Klaveren S; Håkansson M; Diehl C; Kovačič R; Baussière F; Sundin AP; Dernovšek J; Walse B; Zetterberg F; Leffler H; Anderluh M; Tomašič T; Jakopin Ž; Nilsson UJ
    Eur J Med Chem; 2021 Nov; 223():113664. PubMed ID: 34225180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.
    Stowell SR; Arthur CM; Slanina KA; Horton JR; Smith DF; Cummings RD
    J Biol Chem; 2008 Jul; 283(29):20547-59. PubMed ID: 18456665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structure of a protease-resistant mutant form of human galectin-8 with two carbohydrate recognition domains.
    Yoshida H; Yamashita S; Teraoka M; Itoh A; Nakakita S; Nishi N; Kamitori S
    FEBS J; 2012 Oct; 279(20):3937-51. PubMed ID: 22913484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of multivalent lactose derivatives by 1,3-dipolar cycloadditions: selective galectin-1 inhibition.
    Tejler J; Tullberg E; Frejd T; Leffler H; Nilsson UJ
    Carbohydr Res; 2006 Jul; 341(10):1353-62. PubMed ID: 16697988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
    Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
    Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.
    Nielsen MI; Stegmayr J; Grant OC; Yang Z; Nilsson UJ; Boos I; Carlsson MC; Woods RJ; Unverzagt C; Leffler H; Wandall HH
    J Biol Chem; 2018 Dec; 293(52):20249-20262. PubMed ID: 30385505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
    Oberg CT; Blanchard H; Leffler H; Nilsson UJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors.
    Vašíček T; Spiwok V; Červený J; Petrásková L; Bumba L; Vrbata D; Pelantová H; Křen V; Bojarová P
    Chemistry; 2020 Aug; 26(43):9620-9631. PubMed ID: 32368810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.
    Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
    J Biol Chem; 2006 Nov; 281(47):35884-93. PubMed ID: 16990264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.
    Salameh BA; Cumpstey I; Sundin A; Leffler H; Nilsson UJ
    Bioorg Med Chem; 2010 Jul; 18(14):5367-78. PubMed ID: 20538469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.